CN Patent

CN1789250A — 一组硝基咪唑类衍生物的光学对映体、制备方法及其用途

Assigned to Xi'an Pharmaceutical Sci & Tech Co Ltd · Expires 2006-06-21 · 20y expired

What this patent protects

本发明涉及一组硝基咪唑类衍生物的光学对映体制备方法和该类化合物用于制备抗厌氧菌药物、抗原虫的用途。

USPTO Abstract

本发明涉及一组硝基咪唑类衍生物的光学对映体制备方法和该类化合物用于制备抗厌氧菌药物、抗原虫的用途。

Drugs covered by this patent

Solosec (SECNIDAZOLE) · Evofem Inc

Patent Metadata

Patent number: CN1789250A
Jurisdiction: CN
Classification: —
Expires: 2006-06-21
Drug substance claim: No
Drug product claim: No
Assignee: Xi'an Pharmaceutical Sci & Tech Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.